WeedMD Exports Cannabis Genetics to Israeli Partner

WeedMD (TSXV:WMD) announced it exported cannabis genetics to a private medical cannabis producer in Israel.

As quoted in the press release:

WeedMD, a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce it has exported its cannabis genetics to Israel’s Pharmocann, a privately-held pharma-agricultural medical cannabis producer working under the authorization of Israel’s Ministry of Health and widely recognized as a pioneer in the worldwide medical cannabis industry.

“We are delighted that Pharmocann, one of the world leaders and advocates in the medical cannabis community, has selected WeedMD’s genetics to strengthen its robust genetics library. Israel has been researching and advancing medical cannabis for well over 50 years, and Pharmocann has been providing high-quality products to medical patients for over a decade,” said Keith Merker, CEO of WeedMD. “Widely lauded for its breakthrough developments in cannabis treatments, we welcome the Pharmocann team to WeedMD’s expanding list of international genetics customers.”

Click here to read the full press release.

Source: globenewswire.com